Mirum Pharmaceuticals, Inc.
NASDAQ:MIRMBiotechnology
Healthcare
$95.51 +3.81%
+$3.89 today
- Market cap
- $6.24B
- Beta
- 0.51
- P/E (TTM)
- -7.8
- EPS (TTM)
- -$13.57
52W Low $47.89High $114.99
Volume 0.78M
Average 0.95M
Balance Sheet
Inspect the capital base behind the business.
Assets
$842.81M
FY 2025 · Annual
+25.7% YoYLiabilities
$528.12M
FY 2025 · Annual
+18.6% YoYEquity
$314.69M
FY 2025 · Annual
+39.5% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 31.34M | 28M | 286.33M | 222.5M | 296.68M |
| Short-term Investments | 125.2M | 123.72M | 0 | 57.81M | 86.64M |
| Net Receivables | 4.37M | 23.99M | 67.97M | 78.29M | 123.33M |
| Inventory | 1.51M | 5.57M | 22.31M | 22.4M | 24.89M |
| Other Current Assets | 4.17M | 8.95M | 10.94M | 11.78M | 18.14M |
| Total Current Assets | 166.59M | 190.23M | 387.54M | 392.79M | 549.68M |
| Property, Plant & Equipment (Net) | 2.55M | 2.35M | 1.99M | 9.81M | 10.6M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 18.74M | 58.95M | 252.93M | 249.82M | 260.92M |
| Long-term Investments | 4.98M | 0 | 0 | 12.53M | 8.11M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 101.79M | 101.38M | 4.17M | 5.81M | 13.5M |
| Total Non-current Assets | 128.06M | 162.68M | 259.08M | 277.97M | 293.13M |
| Total Assets | 294.65M | 352.91M | 646.62M | 670.75M | 842.81M |
| Account Payables | 9.17M | 8.69M | 7.42M | 14.62M | 9.61M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.98M | 15.75M | 20.94M | 32.25M | 47.28M |
| Total Current Liabilities | 42.6M | 64.73M | 87.06M | 126.55M | 205.8M |
| Long-term Debt | 0 | 0 | 306.42M | 308.08M | 309.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 129.92M | 140.35M | 0 | 0 | 0 |
| Other Non-current Liabilities | 17K | 4.53M | 3.85M | 2.51M | 5.01M |
| Total Non-current Liabilities | 131.84M | 146.14M | 310.89M | 318.56M | 322.32M |
| Total Liabilities | 174.44M | 210.87M | 397.95M | 445.11M | 528.12M |
| Common Stock | 3K | 4K | 5K | 5K | 5K |
| Retained Earnings | (257.16M) | (392.82M) | (556.24M) | (644.18M) | (667.54M) |
| Accumulated OCI | (35K) | (217K) | 1.64M | (373K) | 351K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 120.21M | 142.04M | 248.67M | 225.64M | 314.69M |
| Total Debt | 2.61M | 2.19M | 308.14M | 317.76M | 319.45M |
| Net Debt | (28.73M) | (25.82M) | 21.82M | 95.26M | 22.77M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $330.7M |
| Short-term Investments | $107.6M |
| Receivables | $145.4M |
| Inventory | $25.8M |
| Other Current | $26.9M |
| Total Current Assets | $636.3M |
| PP&E (Net) | $14.3M |
| Intangible Assets | $247.4M |
| Long-term Investments | $123.0M |
| Other Non-current | $24.0M |
| Total Non-current Assets | $408.7M |
| Total Assets | $1.0B |
Analysis
Selected assets total $1.0B for Latest. The largest visible component is Cash & Equivalents at $330.7M, about 31.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 3, 2026 | |
| 8-K | Current report | Nov 3, 2026 |
How much cash does MIRM have?
Mirum Pharmaceuticals, Inc. (MIRM) reported $296.68M in cash and equivalents in fiscal 2025.
How much debt does MIRM carry?
Mirum Pharmaceuticals, Inc. (MIRM) reported $319.45M of total debt, with net debt of $22.77M.
Continue the stock analysis
Jump to another research area for this company.